Organon Analyst Ratings
Organon Analyst Ratings
While ratings are subjective and will change, the latest Organon (OGN) rating was a maintained with a price target of $32.00 to $22.00. The current price Organon (OGN) is trading at is $11.26, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 95.32% | Piper Sandler | $32 → $22 | Maintains | Overweight |
| 11/03/2023 | 42.05% | Goldman Sachs | $33 → $16 | Downgrades | Buy → Neutral |
| 10/25/2023 | 184.1% | Piper Sandler | $33 → $32 | Maintains | Overweight |
| 10/11/2023 | 95.32% | Morgan Stanley | $27 → $22 | Maintains | Equal-Weight |
| 09/21/2023 | 148.59% | Barclays | → $28 | Initiates Coverage On | → Overweight |
| 08/09/2023 | 139.71% | Morgan Stanley | $25 → $27 | Maintains | Equal-Weight |
| 05/08/2023 | 121.95% | Morgan Stanley | $26 → $25 | Maintains | Equal-Weight |
| 03/16/2023 | 192.98% | Raymond James | → $33 | Initiates Coverage On | → Outperform |
| 11/04/2022 | 113.07% | Morgan Stanley | $27 → $24 | Maintains | Equal-Weight |
| 10/14/2022 | 121.95% | B of A Securities | $37 → $25 | Downgrades | Neutral → Underperform |
| 10/12/2022 | 139.71% | Morgan Stanley | $35 → $27 | Maintains | Equal-Weight |
| 09/06/2022 | 201.85% | Piper Sandler | $37 → $34 | Upgrades | Neutral → Overweight |
| 08/05/2022 | 228.49% | B of A Securities | $40 → $37 | Downgrades | Buy → Neutral |
| 07/08/2022 | 201.85% | Morgan Stanley | $35 → $34 | Maintains | Equal-Weight |
| 04/27/2022 | 255.12% | Goldman Sachs | → $40 | Initiates Coverage On | → Buy |
| 04/06/2022 | 210.73% | Morgan Stanley | $37 → $35 | Maintains | Equal-Weight |
| 02/22/2022 | 228.49% | Morgan Stanley | $35 → $37 | Maintains | Equal-Weight |
| 10/07/2021 | 210.73% | Piper Sandler | → $35 | Initiates Coverage On | → Neutral |
| 09/01/2021 | 281.76% | B of A Securities | → $43 | Initiates Coverage On | → Buy |
| 08/16/2021 | 210.73% | Morgan Stanley | $33 → $35 | Maintains | Equal-Weight |
| 07/23/2021 | 210.73% | Citigroup | → $35 | Initiates Coverage On | → Buy |
| 07/22/2021 | 210.73% | Citigroup | → $35 | Initiates Coverage On | → Buy |
| 06/15/2021 | 237.37% | JP Morgan | → $38 | Initiates Coverage On | → Neutral |
| 06/11/2021 | 192.98% | Morgan Stanley | → $33 | Initiates Coverage On | → Equal-Weight |
| 06/10/2021 | — | Evercore ISI Group | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/22/2023 | 95.32% | 派珀·桑德勒 | 32 美元 → 22 美元 | 維護 | 超重 |
| 11/03/2023 | 42.05% | 高盛 | 33 美元 → 16 美元 | 降級 | 買入 → 中性 |
| 2023 年 10 月 25 日 | 184.1% | 派珀·桑德勒 | 33 美元 → 32 美元 | 維護 | 超重 |
| 2023 年 11 月 10 日 | 95.32% | 摩根士丹利 | 27 美元 → 22 美元 | 維護 | 重量相等 |
| 09/21/2023 | 148.59% | 巴克萊 | → 28 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 08/09/2023 | 139.71% | 摩根士丹利 | 25 美元 → 27 美元 | 維護 | 重量相等 |
| 05/08/2023 | 121.95% | 摩根士丹利 | 26 美元 → 25 美元 | 維護 | 重量相等 |
| 03/16/2023 | 192.98% | 雷蒙德·詹姆 | → 33 美元 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
| 2022 年 4 月 11 日 | 113.07% | 摩根士丹利 | 27 美元 → 24 美元 | 維護 | 重量相等 |
| 2022 年 10 月 14 日 | 121.95% | B of A 類證券 | 37 美元 → 25 美元 | 降級 | 中性 → 跑贏大盤 |
| 2022 年 12 月 10 日 | 139.71% | 摩根士丹利 | 35 美元 → 27 美元 | 維護 | 重量相等 |
| 09/06/2022 | 201.85% | 派珀·桑德勒 | 37 美元 → 34 美元 | 升級 | 中性 → 超重 |
| 08/05/2022 | 228.49% | B of A 類證券 | 40 美元 → 37 美元 | 降級 | 買入 → 中性 |
| 07/08/2022 | 201.85% | 摩根士丹利 | 35 美元 → 34 美元 | 維護 | 重量相等 |
| 04/27/2022 | 255.12% | 高盛 | → 40 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 04/06/2022 | 210.73% | 摩根士丹利 | 37 美元 → 35 美元 | 維護 | 重量相等 |
| 02/22/2022 | 228.49% | 摩根士丹利 | 35 美元 → 37 美元 | 維護 | 重量相等 |
| 2021 年 7 月 10 日 | 210.73% | 派珀·桑德勒 | → 35 美元 | 啓動覆蓋範圍開啓 | → 中立 |
| 09/01/2021 | 281.76% | B of A 類證券 | → 43 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2021 年 8 月 16 日 | 210.73% | 摩根士丹利 | 33 美元 → 35 美元 | 維護 | 重量相等 |
| 2021 年 7 月 23 日 | 210.73% | 花旗集團 | → 35 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 07/22/2021 | 210.73% | 花旗集團 | → 35 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 06/15/2021 | 237.37% | 摩根大通 | → 38 美元 | 啓動覆蓋範圍開啓 | → 中立 |
| 06/11/2021 | 192.98% | 摩根士丹利 | → 33 美元 | 啓動覆蓋範圍開啓 | → 重量相等 |
| 06/10/2021 | — | Evercore ISI 集團 | 啓動覆蓋範圍開啓 | → 跑贏大盤 |
What is the target price for Organon (OGN)?
Organon（OGN）的目標價格是多少？
The latest price target for Organon (NYSE: OGN) was reported by Piper Sandler on November 22, 2023. The analyst firm set a price target for $22.00 expecting OGN to rise to within 12 months (a possible 95.32% upside). 8 analyst firms have reported ratings in the last year.
派珀·桑德勒於2023年11月22日公佈了Organon（紐約證券交易所代碼：OGN）的最新目標股價。該分析公司將目標股價定爲22.00美元，預計OGN將在12個月內升至12個月內（可能上漲95.32％）。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Organon (OGN)?
分析師對Organon（OGN）的最新評級是多少？
The latest analyst rating for Organon (NYSE: OGN) was provided by Piper Sandler, and Organon maintained their overweight rating.
Organon（紐約證券交易所代碼：OGN）的最新分析師評級由派珀·桑德勒提供，Organon維持其增持評級。
When is the next analyst rating going to be posted or updated for Organon (OGN)?
Organon（OGN）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Organon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Organon was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表、與Organon的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Organon的最新評級是在2023年11月22日發佈的，因此您應該預計下一個評級將在2024年11月22日左右公佈。
Is the Analyst Rating Organon (OGN) correct?
分析師對 Organon (OGN) 的評級正確嗎？
While ratings are subjective and will change, the latest Organon (OGN) rating was a maintained with a price target of $32.00 to $22.00. The current price Organon (OGN) is trading at is $11.26, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Organon（OGN）評級保持不變，目標股價爲32.00美元至22.00美元。Organon（OGN）的當前交易價格爲11.26美元，超出了分析師的預期區間。
